RAFAEL HOLDINGS, INC. Investments, Fair Value Disclosure
RAFAEL HOLDINGS, INC. (RFL) had Investments, Fair Value Disclosure of $12.01 million as of 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:InvestmentsFairValueDisclosure · last filed 2024-12-20
- 2024-07-31: Investments, Fair Value Disclosure $12.01M.
- 2024-04-30: Investments, Fair Value Disclosure $15.17M.
- 2023-10-31: Investments, Fair Value Disclosure $1.34M.
- 2023-07-31: Investments, Fair Value Disclosure $4.76M; Investments, Fair Value Disclosure as first filed $69.68M.
| Period end | Investments, Fair Value Disclosure | Investments, Fair Value Disclosure as first filed |
|---|---|---|
| 2024-07-31 | $12.01M 10-K/A · filed 2024-12-20 | |
| 2024-04-30 | $15.17M 10-Q · filed 2024-06-14 | |
| 2023-10-31 | $1.34M 10-Q · filed 2023-12-14 | |
| 2023-07-31 | $4.76M 10-K/A · filed 2024-12-20 | $69.68M 10-K · filed 2023-10-30 |
| 2022-07-31 | $41.46M 10-K · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |